The Impact of Grand Tour Cycling on Sleep and the Hematological and Metabolomic Profile in World-class Cyclists
- Conditions
- Overreaching
- Interventions
- Other: Cyclist
- Registration Number
- NCT06386900
- Lead Sponsor
- KU Leuven
- Brief Summary
This project aims to identify the effect of a 3-week Grand Tour (e.g. Tour de France, Giro d'Italia, and Vuelta a España) on sleep, hematological parameters and the serum metabolome in world-class cyclists.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- Male
- Target Recruitment
- 16
- Cylist participating in a Grand Tour (e.g. Tour de France, Vuelta a España, Giro d'Italia)
- /
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Elite cyclists participating in a Grand Tour Cyclist * Sleep metrics will be tracked by a smart ring (OURA Gen3, OURA Health Ltd, Oulu, Finland) starting from one month prior to the start till the end of the Grand Tour * Nocturnal heart rate and heart rate variability will be collected by a smart ring (OURA Gen3, OURA Health Ltd, Oulu, Finland) starting from one month prior till the end of the Grand Tour * Fasted whole blood samples and urine samples will be collected on the morning of (i) the first stage, (ii) the first restday, (iii) second restday, and (iv) last stage of the GrandTour (only in one Grand Tour for a total of 8 cyclists).
- Primary Outcome Measures
Name Time Method Sleep efficiency during the Grand Tour Every night starting from one week before till the last night of the Grand Tour Percentage change in sleep efficiency during the Grand Tour (measured by OURA ring)
Total sleep time during the Grand Tour Every night starting from one week before till the last night of the Grand Tour Change in total sleep time during the Grand Tour (measured by OURA ring)
Blood haemoglobin concentration Start of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand Tour Change in the blood haemoglobin concentration during the Grand Tour
Serum metabolome abundance of cyclists participating in a Grand Tour Start of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand Tour Changes in the abundance of serum metabolites within the cyclists between 4 timepoints (measured by mass spectrometry)
- Secondary Outcome Measures
Name Time Method Light sleep Before the start of the Tour - restday 1 - restday 2 - end of Grand Tour Percentage change in light sleep during the Grand Tour (measured by OURA ring)
REM sleep Before the start of the Tour - restday 1 - restday 2 - end of Grand Tour Percentage change in REM sleep during the Grand Tour (measured by OURA ring)
Deep sleep Before the start of the Tour - restday 1 - restday 2 - end of Grand Tour Percentage change in deep sleep during the Grand Tour (measured by OURA ring)
Wakefulness after sleep onset Every night starting from one week before till the last night of the Grand Tour Percentage change in wakefulness after sleep onset during the Grand Tour (measured by OURA ring)
Red blood cell concentration Start of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand Tour Change in red blood cell concentration during the Grand Tour
Subjective fatigue Start of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand Tour Absolute change in subjective fatigue during the Grand Tour (measured by 11-point scale)
Trial Locations
- Locations (1)
KU Leuven
🇧🇪Leuven, Vlaams-Brabant, Belgium